BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 22795319)

  • 1. Does fructose consumption contribute to non-alcoholic fatty liver disease?
    Tappy L; Lê KA
    Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):554-60. PubMed ID: 22795319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
    Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
    Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fructose in nonalcoholic fatty liver disease.
    Vos MB; Lavine JE
    Hepatology; 2013 Jun; 57(6):2525-31. PubMed ID: 23390127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of fructose.
    Lê KA; Tappy L
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):469-75. PubMed ID: 16778579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
    Nomura K; Yamanouchi T
    J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose and metabolic diseases: new findings, new questions.
    Tappy L; Lê KA; Tran C; Paquot N
    Nutrition; 2010; 26(11-12):1044-9. PubMed ID: 20471804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
    Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
    Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
    Ter Horst KW; Serlie MJ
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
    Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
    Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
    Gugliucci A
    Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
    Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
    Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
    Yki-Järvinen H
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
    Basciano H; Miller AE; Naples M; Baker C; Kohen R; Xu E; Su Q; Allister EM; Wheeler MB; Adeli K
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E462-73. PubMed ID: 19509184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
    Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary fructose on liver steatosis in overfed mule ducks.
    Davail S; Rideau N; Bernadet MD; André JM; Guy G; Hoo-Paris R
    Horm Metab Res; 2005 Jan; 37(1):32-5. PubMed ID: 15702436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content.
    Siddiqui RA; Xu Z; Harvey KA; Pavlina TM; Becker MJ; Zaloga GP
    Nutr Metab (Lond); 2015; 12():41. PubMed ID: 26583036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.